Person:
BÜYÜKPINARBAŞILI, NUR

Loading...
Profile Picture
Google ScholarScopusORCIDPublons
Status
Kurumdan Ayrılmıştır
Organizational Units
Organizational Unit
Job Title
First Name
NUR
Last Name
BÜYÜKPINARBAŞILI
Name
Email Address
Birth Date

Search Results

Now showing 1 - 6 of 6
  • PublicationMetadata only
    Plevral tutlum ile seyreden sarkoidoz vakası
    (2013-04-07) KUTBAY ÖZÇELİK, HATİCE; BAYRAM, MEHMET; BÜYÜKPINARBAŞILI, NUR; KANSU, ABDULLAH; AKKOYUNLU, MUHAMMED EMİN; SEZER, MURAT; KARAKÖSE, FATMANUR; YAKAR, FATİH; KART, LEVENT; BAYRAM, MEHMET; BÜYÜKPINARBAŞILI, NUR; KANSU, ABDULLAH; AKKOYUNLU, MUHAMMED EMİN; OKYALTIRIK, FATMANUR
  • PublicationMetadata only
    Baş boyun kitlelerinde MR perfüzyon bulguları
    (2013-05-25) ARALAŞMAK, AYŞE; YETİŞ, HÜSEYİN; YILDIZ, ŞEYMA; MERİÇ HAFIZ, AYŞENUR; BÜYÜKPINARBAŞILI, NUR; TOPRAK, HÜSEYİN; ALKAN, ALPAY; ARALAŞMAK, AYŞE; YILDIZ, ŞEYMA; MERİÇ HAFIZ, AYŞENUR; BÜYÜKPINARBAŞILI, NUR; TOPRAK, HÜSEYİN; ALKAN, ALPAY
  • PublicationMetadata only
    Somatostatin Analogs Regress Endometriotic Implants in Rats by Decreasing Implant Levels of Vascular Endothelial Growth Factor and Matrix Metaloproteinase 9
    (2013-06-01) Sevket, OSMAN; SEVKET, Asli; MOLLA, Taner; Buyukpinarbasili, NUR; Uysal, Omer; YILMAZ, Bulent; DANE, Banu; KELEKCI, Sefa; ŞEVKET, OSMAN; BÜYÜKPINARBAŞILI, NUR; UYSAL, ÖMER
    Objective: To examine the effect of somatostatin analogs on surgically induced endometriosis in rat models. Study design: Endometrial tissue was implanted onto the abdominal peritoneum of 26 rats that were randomized into 3 groups. The rats in group 1(n = 9) were subcutaneously administered with 0.02 mg/kg/d of octreotide (a short-acting analog) for 28 days. The rats in group 2 (n = 8) were subcutaneously injected with 20 mg/kg of a single dose of a long-acting analogue lanreotide The rats in group 3 were given no medication and served as controls (n = 9). Results: Mean volume and histologic score of implants in groups 1 (P < .01 and P < .05, respectively) and 2 (P < .01 and P < .05, respectively) were significantly lower than that in group 3. There were significant reductions in vascular endothelial growth factor (VEGF) and matrix metalloproteinase 9 (MMP-9) immunoreactivities in group 1 (0.67 +/- 0.50 and 1.22 +/- 0.44, respectively; both P < .01) and group 2 (0.71 +/- 0.48 and 0.86 +/- 0.69, respectively; both P < .01) when compared with the control group (1.78 +/- 0.83 and 2.11 +/- 0.78, respectively). Conclusion: Somatostatin analogs has regressed significantly the size of the endometriotic implants and caused atrophy of these lesions in rats by decreasing explant levels of VEGF and MMP-9.
  • PublicationMetadata only
    MR perfusion findings in head and neck masses
    (2013-04-04) ARALAŞMAK, AYŞE; YETİŞ, HÜSEYİN; YILDIZ, ŞEYMA; MERİÇ HAFIZ, AYŞENUR; BÜYÜKPINARBAŞILI, NUR; TOPRAK, HÜSEYİN; ALKAN, ALPAY; ARALAŞMAK, AYŞE; YILDIZ, ŞEYMA; MERİÇ HAFIZ, AYŞENUR; BÜYÜKPINARBAŞILI, NUR; TOPRAK, HÜSEYİN; ALKAN, ALPAY
  • PublicationMetadata only
    Prevalence of sacrococcygeal pilonidal sinus as a silent disease.
    (2013-11-01) Aysan, E; ILHAN, MAHMUT MUZAFFER; BEKTAS, H; KAYA, EA; SAM, B; BUYUKPINARBASILI, NUR; MUSLUMANOGLU, M; AYŞAN, MUSTAFA ERHAN; İLHAN, MAHMUT MUZAFFER; BÜYÜKPINARBAŞILI, NUR
  • PublicationMetadata only
    The effects of ranibizumab on surgically induced endometriosis in a rat model: a preliminary study.
    (2013-10-01) Sevket, OSMAN; SEVKET, A; BUYUKPıNARBASıLı, NUR; MOLLA, T; KILIC, GÖKHAN; ATES, SEDA; DANSUK, RAMAZAN; ŞEVKET, OSMAN; BÜYÜKPINARBAŞILI, NUR; KILIC, GÖKHAN; ATEŞ, SEDA; DANSUK, RAMAZAN